Sort
21,281 grants matching “influenza”
To employ gamma-peptide nucleic acid oligomers to interfere with viral replication
$236,075Nara Lee · University Of Pittsburgh At Pittsburgh · R21 · FY2022 · AI
Single-cell phospho-protein signaling analysis of the response to influenza vacci
$236,062Garry P Nolan · Stanford University · U19 · FY2012 · AI
Bourbon virus: Therapy development and Serology
$236,000Adrianus Cm Boon · Washington University · R21 · FY2020 · AI
Molecular Evolvability In Theory And In A Bacterial Drug-Resistence Gene
$235,999Daniel L Hartl · Harvard University · · FY2004 · BIO
Baloxavir Derivatives As Inhibitors of Hantavirus Endonuclease Activity
$235,951Erich R. Mackow · State University New York Stony Brook · R21 · FY2020 · AI
Mechanisms by which Influenza A Protects Against Asthma
$235,926Children'S Hospital Boston · R01 · FY2005 · AI
Emerging Infections Program (EIP)/PPACA: Enhancing Epidemiology and Laboratory Ca
$235,911Melissa Tobin-D'angelo · Georgia State Departmentof Public Health · U01 · FY2011 · CI
Rapid detection of infectious viral particles by cluster induced exhaustive reaction
$235,887Jun Wang · State University New York Stony Brook · R21 · FY2022 · AI
Immunity in the Nose to inFLUENza: Correlates of Efficacy (INFLUENCE)
$235,713Ryan Thwaites · Imperial College Of Science, Technology And Medicine · UH3 · FY2025 · AI
Structure/function studies of lactoferrin as a protease
$235,710Tufts Medical Center · R01 · FY2004 · DE
A decision tool to inform the optimal use of non-pharmaceutical interventions during the COVID-19 pandemic
$235,692Reza Yaesoubi · Yale University · R21 · FY2024 · AI
Adjuvanting Vaccine-induced CD8 T Cell Memory Quality Using Regulatory T Cells
$235,623Surojit Sarkar · Seattle Children'S Hospital · R21 · FY2017 · AI
Human Genetic Variation Regulating Transcriptional Response and Cellular Susceptibility to Influenza
$235,610Dennis Chun-Yone Ko · Duke University · R21 · FY2022 · AI
TCR signaling in IL-10 production by CD8+ T cells during influenza-induced lung immunopathology
$235,515Weishan Huang · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2021 · GM
Quantifying the spectrum and dynamics of B-cell binding avidity in response to influenza
$235,500Steven Carl George · University Of California At Davis · R21 · FY2022 · AI
Improving the Immune Response to Nanoparticle-Based SARS-CoV-2 Vaccines
$235,500Szu-Wen Wang · University Of California-Irvine · R21 · FY2023 · AI
Molecular components specifying mucosal cell sensitivity to influenza infection
$235,500Michael A White · Ut Southwestern Medical Center · R21 · FY2010 · AI
Model-Informed Understanding and Mitigation of the U.S. Opioid and Heroin Epidemic
$235,500James C Benneyan · Northeastern University · R21 · FY2018 · DA
BLyS and IFN responses to antigen challenge in human SLE
$235,464Robert H Carter · University Of Alabama At Birmingham · R21 · FY2006 · AI
Comparative Effectiveness Research on Hospital Readmissions for COPD
$235,462Carlos A. Camargo · Massachusetts General Hospital · R01 · FY2015 · HS
Endothelial antigen presentation to T cells as a pathogenic mechanism in influenza-induced acute lung injury
$235,459Lianghui Zhang · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · HL
Centers of Excellence in Influenza Research and Surveillance (CEIRS)
$235,458National Institute Of Allergy And Infectious Diseases · Y01 · FY2008 · AI
Structural Determinants of Human Antibodies neutralizing the Ebola Virus
$235,380Jens Meiler · Vanderbilt University · R21 · FY2017 · AI
Transgenic mouse core
$235,349Stylianos Bournazos · Rockefeller University · U19 · FY2020 · AI
Transgenic mouse core
$235,347Stylianos Bournazos · Rockefeller University · U19 · FY2021 · AI